Form 4 for KURA Kura Oncology, Inc.
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-13 · accession 0001193125-25-283563 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | 2025-11-14 | KURA | Leoni Mollie | Chief Medical Off | S - Sale | $11.18 | -15.5K | 225.5K | -6% | -$173.1K | |
| 2025-11-14 | 2025-11-13 | KURA | Leoni Mollie | Chief Medical Off | A - Grant | $0.00 | +82.5K | 240.9K | +52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-14 | S | D | 15,485 | $11.18 | 225,454 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-13 | A | A | 82,500 | $0.00 | 240,939 | D | — | — |